213 related articles for article (PubMed ID: 38393943)
1. Poly(ADP-ribosyl)ation of TIMELESS limits DNA replication stress and promotes stalled fork protection.
Rageul J; Lo N; Phi AL; Patel JA; Park JJ; Kim H
Cell Rep; 2024 Mar; 43(3):113845. PubMed ID: 38393943
[TBL] [Abstract][Full Text] [Related]
2. [Poly(ADP-Ribose) Polymerases 1 and 2: Classical Functions and Interaction with New Histone Poly(ADP-Ribosyl)ation Factor HPF1].
Kurgina TA; Lavrik OI
Mol Biol (Mosk); 2023; 57(2):254-268. PubMed ID: 37000654
[TBL] [Abstract][Full Text] [Related]
3. The oncoprotein DEK affects the outcome of PARP1/2 inhibition during mild replication stress.
Ganz M; Vogel C; Czada C; Jörke V; Gwosch EC; Kleiner R; Pierzynska-Mach A; Zanacchi FC; Diaspro A; Kappes F; Bürkle A; Ferrando-May E
PLoS One; 2019; 14(8):e0213130. PubMed ID: 31408463
[TBL] [Abstract][Full Text] [Related]
4. PARP1 is activated by membrane damage and is involved in membrane repair through poly(ADP-ribosyl)ation.
Mashimo M; Kita M; Nobeyama A; Nomura A; Fujii T
Genes Cells; 2022 Apr; 27(4):305-312. PubMed ID: 35124853
[TBL] [Abstract][Full Text] [Related]
5. High speed of fork progression induces DNA replication stress and genomic instability.
Maya-Mendoza A; Moudry P; Merchut-Maya JM; Lee M; Strauss R; Bartek J
Nature; 2018 Jul; 559(7713):279-284. PubMed ID: 29950726
[TBL] [Abstract][Full Text] [Related]
6. Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins.
Alemasova EE; Lavrik OI
Nucleic Acids Res; 2019 May; 47(8):3811-3827. PubMed ID: 30799503
[TBL] [Abstract][Full Text] [Related]
7. The TIMELESS and PARP1 interaction suppresses replication-associated DNA gap accumulation.
Saldanha J; Rageul J; Patel JA; Phi AL; Lo N; Park JJ; Kim H
Nucleic Acids Res; 2024 May; ():. PubMed ID: 38801073
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Rad52-dependent replication fork recovery through serine ADP-ribosylation of PolD3.
Richards F; Llorca-Cardenosa MJ; Langton J; Buch-Larsen SC; Shamkhi NF; Sharma AB; Nielsen ML; Lakin ND
Nat Commun; 2023 Jul; 14(1):4310. PubMed ID: 37463936
[TBL] [Abstract][Full Text] [Related]
9. New perspectives on the plant PARP family: Arabidopsis PARP3 is inactive, and PARP1 exhibits predominant poly (ADP-ribose) polymerase activity in response to DNA damage.
Gu Z; Pan W; Chen W; Lian Q; Wu Q; Lv Z; Cheng X; Ge X
BMC Plant Biol; 2019 Aug; 19(1):364. PubMed ID: 31426748
[TBL] [Abstract][Full Text] [Related]
10. Differential and Concordant Roles for Poly(ADP-Ribose) Polymerase 1 and Poly(ADP-Ribose) in Regulating WRN and RECQL5 Activities.
Khadka P; Hsu JK; Veith S; Tadokoro T; Shamanna RA; Mangerich A; Croteau DL; Bohr VA
Mol Cell Biol; 2015 Dec; 35(23):3974-89. PubMed ID: 26391948
[TBL] [Abstract][Full Text] [Related]
11. Role of YB-1 in Regulation of Poly(ADP-Ribosylation) Catalyzed by Poly(ADP-Ribose) Polymerases.
Alemasova EE; Naumenko KN; Sukhanova MV; Lavrik OI
Biochemistry (Mosc); 2022 Jan; 87(Suppl 1):S32-S0. PubMed ID: 35501985
[TBL] [Abstract][Full Text] [Related]
12. Poly-ADP ribosylation in DNA damage response and cancer therapy.
Hou WH; Chen SH; Yu X
Mutat Res Rev Mutat Res; 2019; 780():82-91. PubMed ID: 31395352
[TBL] [Abstract][Full Text] [Related]
13. HDAC inhibitors suppress protein poly(ADP-ribosyl)ation and DNA repair protein levels and phosphorylation status in hematologic cancer cells: implications for their use in combination with PARP inhibitors and chemotherapeutic drugs.
Valdez BC; Nieto Y; Yuan B; Murray D; Andersson BS
Oncotarget; 2022 Oct; 13():1122-1135. PubMed ID: 36243940
[TBL] [Abstract][Full Text] [Related]
14. The C-terminal domain of p53 orchestrates the interplay between non-covalent and covalent poly(ADP-ribosyl)ation of p53 by PARP1.
Fischbach A; Krüger A; Hampp S; Assmann G; Rank L; Hufnagel M; Stöckl MT; Fischer JMF; Veith S; Rossatti P; Ganz M; Ferrando-May E; Hartwig A; Hauser K; Wiesmüller L; Bürkle A; Mangerich A
Nucleic Acids Res; 2018 Jan; 46(2):804-822. PubMed ID: 29216372
[TBL] [Abstract][Full Text] [Related]
15. PARP2 mediates branched poly ADP-ribosylation in response to DNA damage.
Chen Q; Kassab MA; Dantzer F; Yu X
Nat Commun; 2018 Aug; 9(1):3233. PubMed ID: 30104678
[TBL] [Abstract][Full Text] [Related]
16. Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.
Hu K; Wu W; Li Y; Lin L; Chen D; Yan H; Xiao X; Chen H; Chen Z; Zhang Y; Xu S; Guo Y; Koeffler HP; Song E; Yin D
EMBO Rep; 2019 May; 20(5):. PubMed ID: 30940648
[TBL] [Abstract][Full Text] [Related]
17. Poly(ADP-ribosyl)ation of acetyltransferase NAT10 by PARP1 is required for its nucleoplasmic translocation and function in response to DNA damage.
Liu HY; Liu YY; Zhang YL; Ning Y; Zhang FL; Li DQ
Cell Commun Signal; 2022 Aug; 20(1):127. PubMed ID: 35986334
[TBL] [Abstract][Full Text] [Related]
18. Poly(ADP-ribose) polymerase-1 affects vasopressin-mediated AQP2 expression in collecting duct cells of the kidney.
Jang HJ; Park E; Jung HJ; Kwon TH
Am J Physiol Renal Physiol; 2024 Jan; 326(1):F69-F85. PubMed ID: 37855039
[TBL] [Abstract][Full Text] [Related]
19. Poly(ADP-ribose) polymerase is hyperactivated in homologous recombination-defective cells.
Gottipati P; Vischioni B; Schultz N; Solomons J; Bryant HE; Djureinovic T; Issaeva N; Sleeth K; Sharma RA; Helleday T
Cancer Res; 2010 Jul; 70(13):5389-98. PubMed ID: 20551068
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic insight into the role of Poly(ADP-ribosyl)ation in DNA topology modulation and response to DNA damage.
Matkarimov BT; Zharkov DO; Saparbaev MK
Mutagenesis; 2020 Feb; 35(1):107-118. PubMed ID: 31782485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]